Diffuse large B cell lymphoma CT

Jump to navigation Jump to search

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma CT

CDC on Diffuse large B cell lymphoma CT

Diffuse large B cell lymphoma CT in the news

Blogs on Diffuse large B cell lymphoma CT

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Anila Hussain, MD [3]

Overview

CT scan may be helpful in the diagnosis and Staging of diffuse large B cell lymphoma.

CT scan

CT scan may be helpful in the diagnosis of diffuse large B cell lymphoma[1]. Fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) scan is now recommended as the gold standard for staging DLBCL patients. PET/CT has high Sensitivity for nodal and extranodal sites and is superior to contrast enhanced CT, although Contrast CT is usually done before PET/CT in practice.

References

  1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov


Template:WikiDoc Sources